Modeling the specific CD4+ T cell response against a tumor neoantigen.

Autor: Flament H; INSERM U932, Institut Curie, 75005 Paris, France;, Alonso Ramirez R; INSERM U932, Institut Curie, 75005 Paris, France;, Prémel V; INSERM U932, Institut Curie, 75005 Paris, France;, Joncker NT; INSERM U932, Institut Curie, 75005 Paris, France;, Jacquet A; INSERM U932, Institut Curie, 75005 Paris, France;, Scholl S; Center of Clinical Investigations in Biotherapy 1428 (Institut Gustave Roussy/Curie), Institut Curie, 75005 Paris, France; and Department of Medical Oncology, Institut Curie, 75005 Paris, France., Lantz O; INSERM U932, Institut Curie, 75005 Paris, France; Center of Clinical Investigations in Biotherapy 1428 (Institut Gustave Roussy/Curie), Institut Curie, 75005 Paris, France; and olivier.lantz@curie.fr.

Publikováno v: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2015 Apr 01; Vol. 194 (7), pp. 3501-12. Date of Electronic Publication: 2015 Mar 02.

Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases.

Autor: Alonso-Ramirez R; EA2216 Immunology and Pathology and IFR 148 ScInBioS, European University of Brittany, BP 824, 29609 Brest, France., Loisel S, Buors C, Pers JO, Montero E, Youinou P, Renaudineau Y

Publikováno v: Arthritis [Arthritis] 2010; Vol. 2010, pp. 130646. Date of Electronic Publication: 2011 Feb 10.

Genetic susceptibility to temporomandibular joint involvement in juvenile idiopathic arthritis.

Autor: Niibo P; Institute of Dentistry, University of Tartu, Tartu, Estonia., Nikopensius T; Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia., Jagomägi T; Institute of Dentistry, University of Tartu, Tartu, Estonia., Voog Ü; Institute of Dentistry, University of Tartu, Tartu, Estonia.; Stomatology Clinic, Tartu University Hospital, Tartu, Estonia., Haller T; Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia., Tõnisson N; Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia.; Department of Clinical Genetics, United Laboratories, Tartu University Hospital, Tartu, Estonia., Metspalu A; Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia., Saag M; Institute of Dentistry, University of Tartu, Tartu, Estonia., Pruunsild C; Children's Clinic, Tartu University Hospital, Tartu, Estonia.; Children's Clinic, Institute of Clinical Medicine, Faculty of Medicine, University of Tartu, Tartu, Estonia.

Publikováno v: Journal of oral rehabilitation [J Oral Rehabil] 2024 Nov; Vol. 51 (11), pp. 2445-2451. Date of Electronic Publication: 2024 Aug 27.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design.

Autor: Cai, Weijing¹ caiweijing816@163.com, Zhou, Dapeng¹ dapengzhoulab@tongji.edu.cn, Wu, Weibo¹ violetwwb@163.com, Tan, Wen Ling¹ 1593178@tongji.edu.cn, Wang, Jiaqian² wangjq@yucebio.com, Zhou, Caicun¹ caicunzhou_dr@163.com, Lou, Yanyan³ Lou.Yanyan@mayo.edu

Publikováno v: BMC Genomics. 8/3/2018, Vol. 19 Issue 1, p1-9. 9p. 1 Diagram, 3 Charts, 2 Graphs.